Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Helwig

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Immunology|April 12, 2001
Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitisT Kühbacher, P Gionchetti, J Hampe, et al.
The British Journal of Nutrition|July 20, 2012
A common haplotype of carnitine palmitoyltransferase 1b is associated with the metabolic syndromeA Auinger, D Rubin, M Sabandal, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 15, 2010
A promoter polymorphism in the liver-specific fatty acid transport protein 5 is associated with features of the metabolic syndrome and steatosisA Auinger, L Valenti, M Pfeuffer, et al.
The American Journal of Gastroenterology|May 17, 2002
Effect of probiotic strains on interleukin 8 production by HT29/19A cellsK M Lammers, U Helwig, E Swennen, et al.
Lipids in Health and Disease|August 20, 2009
Isomer-specific effects of CLA on gene expression in human adipose tissue depending on PPARgamma2 P12A polymorphism: a double blind, randomized, controlled cross-over studyJ Herrmann, D Rubin, R Häsler, et al.
Gut|December 20, 2003
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitisT Mimura, F Rizzello, U Helwig, et al.
Alimentary Pharmacology & Therapeutics|April 23, 2002
Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitisT Mimura, F Rizzello, U Helwig, et al.
International Journal of Colorectal Disease|November 30, 2002
The effect of transient intestinal ischemia on inflammatory parametersK M Lammers, G Innocenti, A Venturi, et al.
Zeitschrift Fur Gastroenterologie|July 5, 2012
[Rational and efficient diagnosis in different stages of Crohn's disease]N Teich, U Helwig, A Pace, et al.
The American Journal of Gastroenterology|September 25, 2001
Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatmentS Ulisse, P Gionchetti, S D'Alò, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Immunology|April 12, 2001
Activation of signal-transducer and activator of transcription 1 (STAT1) in pouchitisT Kühbacher, P Gionchetti, J Hampe, et al.
The British Journal of Nutrition|July 20, 2012
A common haplotype of carnitine palmitoyltransferase 1b is associated with the metabolic syndromeA Auinger, D Rubin, M Sabandal, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 15, 2010
A promoter polymorphism in the liver-specific fatty acid transport protein 5 is associated with features of the metabolic syndrome and steatosisA Auinger, L Valenti, M Pfeuffer, et al.
The American Journal of Gastroenterology|May 17, 2002
Effect of probiotic strains on interleukin 8 production by HT29/19A cellsK M Lammers, U Helwig, E Swennen, et al.
Lipids in Health and Disease|August 20, 2009
Isomer-specific effects of CLA on gene expression in human adipose tissue depending on PPARgamma2 P12A polymorphism: a double blind, randomized, controlled cross-over studyJ Herrmann, D Rubin, R Häsler, et al.
Gut|December 20, 2003
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitisT Mimura, F Rizzello, U Helwig, et al.
Alimentary Pharmacology & Therapeutics|April 23, 2002
Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitisT Mimura, F Rizzello, U Helwig, et al.
International Journal of Colorectal Disease|November 30, 2002
The effect of transient intestinal ischemia on inflammatory parametersK M Lammers, G Innocenti, A Venturi, et al.
Zeitschrift Fur Gastroenterologie|July 5, 2012
[Rational and efficient diagnosis in different stages of Crohn's disease]N Teich, U Helwig, A Pace, et al.
The American Journal of Gastroenterology|September 25, 2001
Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatmentS Ulisse, P Gionchetti, S D'Alò, et al.
Pageof 4